Literature DB >> 27305189

State Initiatives to Control Medication Costs--Can Transparency Legislation Help?

Ameet Sarpatwari1, Jerry Avorn1, Aaron S Kesselheim1.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27305189     DOI: 10.1056/NEJMp1605100

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  The Cost-Benefit Balance of Statins in Hawai'i: A Moving Target.

Authors:  Corey J Lum; Kazuma Nakagawa; Ralph V Shohet; Todd B Seto; Deborah A Taira
Journal:  Hawaii J Med Public Health       Date:  2017-04

2.  Prevalence and Correlates of Medical Financial Hardship in the USA.

Authors:  K Robin Yabroff; Jingxuan Zhao; Xuesong Han; Zhiyuan Zheng
Journal:  J Gen Intern Med       Date:  2019-05-01       Impact factor: 5.128

Review 3.  Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA.

Authors:  Daniel M Hartung
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 4.  The high price of anticancer drugs: origins, implications, barriers, solutions.

Authors:  Vinay Prasad; Kevin De Jesús; Sham Mailankody
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675

5.  Patterns and predictors of physician adoption of new cardiovascular drugs.

Authors:  Timothy S Anderson; Wei-Hsuan Lo-Ciganic; Walid F Gellad; Rouxin Zhang; Haiden A Huskamp; Niteesh K Choudhry; Chung-Chou H Chang; Seth Richards-Shubik; Hasan Guclu; Bobby Jones; Julie M Donohue
Journal:  Healthc (Amst)       Date:  2017-10-21

Review 6.  Financial toxicity and implications for cancer care in the era of molecular and immune therapies.

Authors:  George Tran; S Yousuf Zafar
Journal:  Ann Transl Med       Date:  2018-05

Review 7.  Origins of the Crisis in Insulin Affordability and Practical Advice for Clinicians on Using Human Insulin.

Authors:  Jing Luo; Walid F Gellad
Journal:  Curr Diab Rep       Date:  2020-01-29       Impact factor: 5.430

8.  What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension.

Authors:  Robyn Tamblyn; Nancy Winslade; Christina J Qian; Teresa Moraga; Allen Huang
Journal:  Implement Sci       Date:  2018-01-10       Impact factor: 7.327

Review 9.  Integrins as Therapeutic Targets: Successes and Cancers.

Authors:  Sabine Raab-Westphal; John F Marshall; Simon L Goodman
Journal:  Cancers (Basel)       Date:  2017-08-23       Impact factor: 6.639

10.  Analysis of State-Level Drug Pricing Transparency Laws in the United States.

Authors:  Martha S Ryan; Neeraj Sood
Journal:  JAMA Netw Open       Date:  2019-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.